News Chart GlycoNex Incorporation

Equities

4168

TW0004168000

End-of-day quote Taipei Exchange Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
28.2 ^TWD	+9.94%		+13.25%	-5.21%

05-28	Glyconex and Precisemab Sign Technology Licensing Agreement to Advance Development of Novel Anti-Glycan Antibodies for Cancer Therapy	CI
05-14	GlycoNex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

8a210d921cd754.bRvFbO-DyHaiuR4uiKFX-egf9XSyWKU-zjCgtzKjlJ0.W2iNDYXWhwKaj3VWyeIvzYJsr0z5KctJm3PE4mHb5vNeXJIrlbSPRZTAXw~7b73823ec7d9076c973e850560e0fe72